Canada
Health Canada approves dandelion extract trials in humans
Posted November 24th, 2012 by adminHealth Canada has approved early clinical trials of dandelion extract to see if it can be used to kill cancer.
The approval is for a phase one — or toxicology — trial. It will determine whether the body can tolerate the dandelion extract and, if it can, how much of the extract the human body can tolerate.
Phase one trials do not reveal whether the substance being tested has a medicinal effect.
Increased risk for hepatitis C associated with solvent use among Canadian Aboriginal injection drug users
Posted August 2nd, 2010 by adminSolvent abuse is a particularly serious issue affecting Aboriginal
people. Here we examine the association between solvent use and
socio-demographic variables, drug-related risk factors, and pathogen
prevalence in Aboriginal injection drug users (IDU) in Manitoba, Canada.
Methods: Data originated from a cross-sectional survey of IDU from December 2003 to September 2004.
Associations between solvent use and variables of interest were assessed by multiple logistic regression.
Results:
A total of 266 Aboriginal IDU were included in the analysis of which 44
Hep C victims deserve better
Posted June 9th, 2010 by adminLee Prokaska It is virtually impossible to put an accurate and true dollar value on a loved one lost. But when a mechanism is set up to try to do that, when responsibility is accepted by government, it is unacceptable for families to lose yet again by failing to receive the full compensation
they deserve.
The Hamilton Spectator Canada
(Jun 3, 2010)

